CD274 and neoplasm: Additionally, the stimulatory effect of activated T cells on tumor cells prompts the production of more EVs, thereby increasing the levels of PD-L1-EVs and forming a mechanism that counteracts the efficacy of anti-PD-L1 therapy89.